Phthalate exposure in the neonatal intensive care unit is associated with development of bronchopulmonary dysplasia

Annemarie Stroustrup, Xueying Zhang, Emily Spear, Sanjukta Bandyopadhyay, Srinivasan Narasimhan, Anil K. Meher, Jaeun Choi, Gao Qi, Brenda B. Poindexter, Susan L. Teitelbaum, Syam S. Andra, Chris Gennings, Judy L. Aschner

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Objective: Bronchopulmonary dysplasia (BPD) is a serious yet common morbidity of preterm birth. Although prior work suggests a possible role for phthalate exposure in the development of BPD, no study has rigorously evaluated this. Our objective was to determine whether hospital-based phthalate exposure is associated with the development of BPD and to identify developmental windows sensitive to exposure. Study Design: This is a prospective multicenter cohort study of 360 preterm infants born at 23–33 weeks gestation participating in the Developmental Impact of NICU Exposures (DINE) cohort. 939 urine specimens collected during the NICU stay were analyzed for biomarkers of phthalate exposure by liquid chromatography with tandem mass spectrometry. The modified Shennan definition was used to diagnose bronchopulmonary dysplasia. Reverse distributed-lag modeling identified developmental windows sensitive to specific phthalate exposure, controlling for relevant covariates including sex and respiratory support. Results: Thirty-five percent of participants were diagnosed with BPD. Exposure to specific phthalate mixtures at susceptible points in preterm infant development are associated with later diagnosis of BPD in models adjusted for use of respiratory support. The weighted influence of specific phthalate metabolites in the mixtures varied by sex. Metabolites of di(2-ethylhexyl) phthalate, a phthalate previously linked to neonatal respiratory support equipment, drove this association, particularly among female infants, at 26- to 30-weeks post-menstrual age. Conclusions: This is the largest and only multi-site study of NICU-based phthalate exposure and clinical impact yet reported. In well-constructed models accounting for infant sex and respiratory support, we found a significant positive association between ultimate diagnosis of BPD and prior exposure to phthalate mixtures with DEHP predominance at 26- to 30-weeks PMA or 34–36-weeks PMA. This information is critically important as it identifies a previously unrecognized and modifiable contributing factor to BPD.

Original languageEnglish (US)
Article number108117
JournalEnvironment international
Volume178
DOIs
StatePublished - Aug 2023
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2023

Keywords

  • Bronchopulmonary dysplasia
  • Chronic lung disease of prematurity
  • DEHP
  • Neonatal intensive care
  • Phthalate
  • Preterm birth

PubMed: MeSH publication types

  • Multicenter Study
  • Journal Article
  • Research Support, N.I.H., Extramural

Fingerprint

Dive into the research topics of 'Phthalate exposure in the neonatal intensive care unit is associated with development of bronchopulmonary dysplasia'. Together they form a unique fingerprint.

Cite this